Over a median of 3.68 years, adults with type 2 diabetes who added a GLP-1 agent to their treatment ... likely driven by two main mechanisms of action -- the first being a reduction in obesity ...

Tirzepatide includes blockbuster injected GLP-1 meds Mounjaro (for diabetes ... "FDA may still take action regarding violations of any other statutory or regulatory requirements, such as to ...

Share on Pinterest A new study compares the risks and benefits of using GLP-1 medications. Iuliia Burmistrova/Getty Images The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists ...

Amanda Bonello – who lives in Iowa – decided to take action. “I haven't seen any ... more than 15,000 clients with compounded GLP-1. “Compounded products are very clean, very simple ...

Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” A Type 2 diabetes medication that can also aid in weight loss ...

How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found ... for cravings—the same mechanism that could contribute to weight ...

NEW YORK — Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer ...

The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based ... both have a long duration of action, allowing once-daily administration.

Coya Therapeutics expands its pipeline, advancing COYA 303 with a dual immunomodulatory mechanism for inflammatory ... a glucagon-like-peptide-1 receptor agonist (GLP-1 RA) designed for ...